Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Megafine Pharma
Manufacturing
Megafine busted by second FDA warning letter in less than a year
India’s Megafine Pharma has received its second FDA warning letter in 10 months, this one for an API intermediates plant in India.
Eric Palmer
Mar 7, 2017 11:56am
India to start fresh on pharma oversight by reworking 75-year-old law
Jun 22, 2016 11:16am
FDA whacks Megafine India API plant with warning for faked test data
May 31, 2016 1:17pm